HyperMabs is a biopharmaceutical company that designs and develops
innovative monoclonal antibody-based therapeutics for life threatening
diseases including COVID-19. We believe in connecting rigorous science with
our innate sense of urgency to rapidly generate breakthrough therapies for
patients in need of a better quality of life. Our highly qualified team of drug
developers and company builders has a track record of advancing complex
biologics from discovery through clinical trials.

Biotechnology

Clinical Trials

Life Sciences

Pharmaceutical

Therapeutics

HyperMabs Inc.

The Montreal office focuses on biotech research, translational science, and data analysis to drive innovation in life sciences.

Montreal

Frank van Lier

This department focuses on bridging the gap between laboratory research and clinical applications, facilitating the development of new therapies and treatments.

Translational Science

This department focuses on analyzing complex data sets to extract insights and inform decision-making.

Data Science

This department focuses on conducting research and development activities to advance analytical methodologies and product innovation.

Research Development

This department oversees the management and efficiency of laboratory processes and technician activities.

Laboratory Operations

This department provides legal guidance and financial analysis to support the organization's strategic objectives.

Legal and Finance

This department oversees all aspects of the manufacturing process, ensuring efficient production and quality control.

HyperMabs Inc.

Org chart

Teams

Translational Science

Data Science

Research Development

Laboratory Operations

Legal and Finance

Manufacturing Division

Offices

HyperMabs Inc.

Org chart

Teams

Translational Science

Data Science

Research Development

Laboratory Operations

Legal and Finance

Manufacturing Division

Offices

Related companies